Top Institutions in Infectious Diseases / Tuberculosis Prevention
Leading institutions in TB research utilize randomized controlled trials, pharmacokinetic and pharmacogenomic studies, and large-scale epidemiological surveillance to establish evidence for TB prevention regimens. They also focus on treatment adherence, safety profiles, and regimen optimization in special populations including immunosuppressed patients.
-
#1
Centers for Disease Control and Prevention (CDC) - Division of Tuberculosis Elimination
Atlanta, GA
The CDC leads national and global TB prevention efforts with extensive expertise in clinical trials, epidemiology, and guideline development for TB treatment and prevention, including shorter regimens.
Key Differentiators
- Infectious Diseases
- Tuberculosis Research
- Public Health
-
#2
The Tuberculosis Research Unit, Johns Hopkins University
Baltimore, MD
Johns Hopkins has a strong track record in TB clinical research, including pioneering studies on TB preventive therapy regimens and pharmacokinetics of anti-TB drugs.
Key Differentiators
- Infectious Diseases
- TB Clinical Trials
- Pharmacology
-
#3
The London School of Hygiene & Tropical Medicine (LSHTM)
London, UK
LSHTM is internationally recognized for its TB research, including clinical trials on TB preventive therapy and implementation research in high-burden settings.
Key Differentiators
- Epidemiology
- Infectious Diseases
- Global Health
-
#4
Chinese Center for Disease Control and Prevention (China CDC)
Beijing, China
China CDC has significant expertise in TB epidemiology and clinical trials within China, including recent studies on shorter TB preventive regimens in high-risk populations.
Key Differentiators
- Infectious Diseases
- TB Control
- Clinical Research
-
#5
National Institute of Allergy and Infectious Diseases (NIAID), NIH
Bethesda, MD
NIAID supports and conducts extensive research on TB pathogenesis, treatment, and prevention, including funding clinical trials for novel TB preventive regimens.
Key Differentiators
- Infectious Diseases
- Immunology
- Clinical Trials
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
